Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$38,748,756
+$18,791,078 QoQ
Shares Held
454,851
+50.2% QoQ
Ownership
0.327%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#64
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 97%
None 3%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Mar 31, 2026CallValue
$11,975,847
CallShares
181,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. CYTK ranks #22 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in CYTK
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,748,756 | 454,851 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $11,975,847 | 181,700 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $19,957,678 | 302,802 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $34,680,447 | 545,805 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $31,027,501 | 564,547 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $11,397,675 | 344,966 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $31,612,768 | 786,583 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $35,392,941 | 752,401 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $28,624,725 | 542,135 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $18,645,176 | 344,134 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $20,613,950 | 294,023 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $28,157,419 | 337,255 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $9,292,214 | 315,418 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $11,256,118 | 345,068 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $14,116,609 | 401,154 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $19,124,901 | 417,392 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $26,303,311 | 542,896 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $22,055,126 | 561,342 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $20,575,685 | 558,970 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $25,505,746 | 559,582 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $12,631,766 | 353,435 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,234,284 | 315,022 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $7,350,834 | 316,029 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $6,258,437 | 301,176 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,768,287 | 312,623 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $6,494,949 | 275,560 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,638,924 | 308,645 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||